Benchmark Capital Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $6K | Sell |
2,173
-1,387
| -39% | -$3.83K | 0.01% | 113 |
|
|
2018
Q3 | $24K | Sell |
3,560
-67
| -2% | -$452 | 0.02% | 132 |
|
|
2018
Q2 | $27K | Sell |
3,627
-40
| -1% | -$298 | 0.02% | 128 |
|
|
2018
Q1 | $128K | Sell |
3,667
-400
| -10% | -$14K | 0.1% | 122 |
|
|
2017
Q4 | $173K | Sell |
4,067
-253
| -6% | -$10.8K | 0.14% | 120 |
|
|
2017
Q3 | $185K | Hold |
4,320
| – | – | 0.14% | 124 |
|
|
2017
Q2 | $160K | Hold |
4,320
| – | – | 0.13% | 122 |
|
|
2017
Q1 | $234K | Sell |
4,320
-133
| -3% | -$7.2K | 0.18% | 101 |
|
|
2016
Q4 | $236K | Sell |
4,453
-14
| -0.3% | -$742 | 0.2% | 99 |
|
|
2016
Q3 | $271K | Hold |
4,467
| – | – | 0.2% | 98 |
|
|
2016
Q2 | $294K | Sell |
4,467
-366
| -8% | -$24.1K | 0.24% | 92 |
|
|
2016
Q1 | $274K | Buy |
4,833
+3,490
| +260% | +$198K | 0.24% | 88 |
|
|
2015
Q4 | $316K | Buy |
+1,343
| New | +$316K | 0.27% | 78 |
|